For patienter, som fik fibrinolyse, opstod der alvorlige blødninger blandt 1. 3% af fondaparinuxpatienter og 2, 0% af patienterne i kontrolgruppen.
By Day 9, 1.1% of patients treated with fondaparinux and 1.4% of control patients experienced a severe haemorrhage.